Medicine Man Technologies, Inc.
OTC:SHWZ
0.6102 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 172.448 | 159.379 | 108.42 | 24.001 | 10.618 | 7.924 | 3.53 | 0.631 | 0.836 | 0.252 |
| Cost of Revenue
| 96.424 | 74.349 | 59.067 | 17.226 | 7.616 | 2.578 | 1.302 | 0.462 | 0.21 | 0.072 |
| Gross Profit
| 76.024 | 85.03 | 49.354 | 6.774 | 3.002 | 5.347 | 2.227 | 0.169 | 0.626 | 0.18 |
| Gross Profit Ratio
| 0.441 | 0.534 | 0.455 | 0.282 | 0.283 | 0.675 | 0.631 | 0.268 | 0.749 | 0.714 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 70.933 | 64.164 | 38.945 | 29.677 | 16.466 | 4.403 | 7.129 | 1.01 | 0.52 | 0.193 |
| Selling & Marketing Expenses
| 0 | -34.765 | 0 | 0 | 0 | 0.292 | 0.184 | 0.312 | 0.016 | 0.015 |
| SG&A
| 70.933 | 64.164 | 38.945 | 29.677 | 16.466 | 4.695 | 7.313 | 1.321 | 0.536 | 0.209 |
| Other Expenses
| 1.802 | 0.024 | 22.328 | 0.033 | 11.989 | 1.374 | -0.07 | 0.165 | 0 | 0 |
| Operating Expenses
| 72.735 | 64.164 | 38.945 | 29.677 | 16.466 | 4.695 | 7.313 | 1.321 | 0.536 | 0.209 |
| Operating Income
| 3.289 | 20.89 | -5.111 | -22.903 | -13.464 | 2.17 | -5.236 | -1.152 | 0.09 | -0.029 |
| Operating Income Ratio
| 0.019 | 0.131 | -0.047 | -0.954 | -1.268 | 0.274 | -1.483 | -1.824 | 0.108 | -0.114 |
| Total Other Income Expenses Net
| -18.097 | -16.424 | 8.506 | 2.587 | -0.477 | -0.638 | -0.145 | -0.312 | 0.008 | 0.002 |
| Income Before Tax
| -14.809 | -3.57 | 18.915 | -20.316 | -17.559 | 1.532 | -5.381 | -1.464 | 0.098 | -0.027 |
| Income Before Tax Ratio
| -0.086 | -0.022 | 0.174 | -0.846 | -1.654 | 0.193 | -1.525 | -2.319 | 0.118 | -0.106 |
| Income Tax Expense
| 19.741 | 14.898 | 4.396 | -0.899 | -0.583 | 0.583 | 0.016 | 0.125 | 0.012 | 0.003 |
| Net Income
| -34.549 | -18.468 | 14.519 | -19.417 | -16.976 | 0.949 | -5.381 | -1.464 | 0.086 | -0.03 |
| Net Income Ratio
| -0.2 | -0.116 | 0.134 | -0.809 | -1.599 | 0.12 | -1.525 | -2.319 | 0.103 | -0.119 |
| EPS
| -0.26 | -0.34 | 0.17 | -0.47 | -0.5 | 0.034 | -0.23 | -0.14 | 0.01 | -0.003 |
| EPS Diluted
| -0.26 | -0.34 | -0.055 | -0.47 | -0.5 | 0.034 | -0.23 | -0.14 | 0.01 | -0.003 |
| EBITDA
| 37.518 | 38.119 | 3.466 | -19.798 | -13.553 | 1.614 | -5.231 | -1.425 | 0.097 | -0.03 |
| EBITDA Ratio
| 0.218 | 0.2 | 0.032 | -1.043 | -0.892 | 0.096 | -1.434 | -1.775 | 0.116 | -0.1 |